Genomic characterisation of pulmonary subsolid nodules: mutational landscape and radiological features

Background Lung adenocarcinomas (LUADs) that display radiologically as subsolid nodules (SSNs) exhibit more indolent biological behaviour than solid LUADs. SSNs, commonly encompassing pre-invasive and invasive yet early-stage adenocarcinomas, can be categorised as pure ground-glass nodules and part-solid nodules. The genomic characteristics of SSNs remain poorly understood. Methods We subjected 154 SSN samples from 120 treatment-naïve Chinese patients to whole-exome sequencing. Clinical parameters and radiological features of these SSNs were collected. The genomic landscape of SSNs and differences from that of advanced-stage LUADs were defined. In addition, we investigated the intratumour heterogeneity and clonal relationship of multifocal SSNs and conducted radiogenomic analysis to link imaging and molecular characteristics of SSNs. Fisher's exact and Wilcoxon rank sum tests were used in the statistical analysis. Results The median somatic mutation rate across the SSN cohort was 1.12 mutations per Mb. Mutations in EGFR were the most prominent and significant variation, followed by those in RBM10, TP53, STK11 and KRAS. The differences between SSNs and advanced-stage LUADs at a genomic level were unravelled. Branched evolution and remarkable genomic heterogeneity were demonstrated in SSNs. Although multicentric origin was predominant, we also detected early metastatic events among multifocal SSNs. Using radiogenomic analysis, we found that higher ratios of solid components in SSNs were accompanied by significantly higher mutation frequencies in EGFR, TP53, RBM10 and ARID1B, suggesting that these genes play roles in the progression of LUADs. Conclusions Our study provides the first comprehensive description of the mutational landscape and radiogenomic mapping of SSNs. This study provides the first comprehensive description of the mutational landscape of SSNs and reveals the potential genomic grounds supporting the use of radiological parameters as clinical references for diagnosis and treatment of SSNs http://bit.ly/2NDmV31

[1]  Yi-long Wu,et al.  Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early-Invasive Lung Adenocarcinoma. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[2]  Xiaodong Yang,et al.  Ground glass opacities: Imaging, pathology, and gene mutations , 2018, The Journal of thoracic and cardiovascular surgery.

[3]  Y. Hua,et al.  CT features differentiating pre- and minimally invasive from invasive adenocarcinoma appearing as mixed ground-glass nodules: mass is a potential imaging biomarker. , 2018, Clinical radiology.

[4]  Steven J. M. Jones,et al.  Oncogenic Signaling Pathways in The Cancer Genome Atlas. , 2018, Cell.

[5]  K. Inamura Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression , 2018, International journal of molecular sciences.

[6]  Zaw Win Aung,et al.  Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing , 2018, Nature Communications.

[7]  D. Shen,et al.  Early metastasis detected in patients with multifocal pulmonary ground-glass opacities (GGOs) , 2017, Thorax.

[8]  Kenji Suzuki,et al.  DNA mismatch repair deficiency in surgically resected lung adenocarcinoma: Microsatellite instability analysis using the Promega panel. , 2017, Lung cancer.

[9]  A. Bankier,et al.  Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. , 2017, Radiology.

[10]  I. Wistuba,et al.  Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  P. Brennan,et al.  Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma , 2016, Scientific Reports.

[12]  K. Ashizawa,et al.  Natural History of Pulmonary Subsolid Nodules: A Prospective Multicenter Study , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  Chandra Sekhar Pedamallu,et al.  Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas , 2016, Nature Genetics.

[14]  Xun Xu,et al.  Frequent alterations in cytoskeleton remodelling genes in primary and metastatic lung adenocarcinomas , 2015, Nature Communications.

[15]  Siân Jones,et al.  Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA , 2015, Nature Communications.

[16]  C. Swanton,et al.  Analysis of intratumor heterogeneity unravels lung cancer evolution , 2015, Molecular & cellular oncology.

[17]  Y. Yatabe,et al.  Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  Z. Szallasi,et al.  Spatial and temporal diversity in genomic instability processes defines lung cancer evolution , 2014, Science.

[19]  J. Gagné,et al.  Germline mutations in BAP1 impair its function in DNA double-strand break repair. , 2014, Cancer research.

[20]  Steven J. M. Jones,et al.  Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.

[21]  T. Nagase,et al.  SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability. , 2014, Cancer research.

[22]  D. Higgs,et al.  The chromatin remodeller ATRX: a repeat offender in human disease. , 2013, Trends in biochemical sciences.

[23]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[24]  Angela N. Brooks,et al.  Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing , 2012, Cell.

[25]  W. Nishio,et al.  Survival of 1737 lobectomy-tolerable patients who underwent limited resection for cStage IA non-small-cell lung cancer. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[26]  Guo-Min Li,et al.  Mechanisms and functions of DNA mismatch repair , 2008, Cell Research.